Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Post by Genie29jon Mar 31, 2023 11:20pm
197 Views
Post# 35373272

58 days

58 days

58 days before the trial with Shiseido... 

I am a gambling man (clearly with my xxxk shares in this company), but man I have have mixed feeling about this. 

One would think if Shiseido wants to avoid the public exposure of the court system, the dialog would have started by now, or very soon. 

But do they really care if it hits the courts? I mean, companies in general are in court battles ALL THE TIME. Shiseido is a conglomerate powerhouse and as a result, have powerhouse attorneys. If they believe they are right, why wouldn't they take it all the way? What's stopping them? They fight for their rights constantly, why would they treat this any different?

But then again, if they do go to courts and battle, that has to be a good sign that IT WORKS! And if Shiseido wins,  Replicel will need more cash to start marketing this elsewhere. (Probably easier said than done), but one would think Replicel has the secret sauce 

dunno,,, just thinking out loud.

thoughts? 

<< Previous
Bullboard Posts
Next >>